More on RDNT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $68.41 |
|
|||
| Open | $68.41 | ||||
| 52 Wk High | $7.98 | ||||
| 52 Wk Low | $4.66 | ||||
| Day High | $68.41 | ||||
| Day Low | $68.41 | ||||
| P/E | 46.86 | ||||
| EPS | $1.46 | ||||
| Volume | 2,161 | ||||
- New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies
- RadNet partners with WIN-NextGen to recruit youth into medical imaging
- RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
- Raymond James Assumes RadNet (RDNT) at Strong Buy
- TD Cowen Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
- Acadia Pharmaceuticals (ACAD) PT Lowered to $34 at BMO Capital Amid Heavy Selling
- Raymond James Reiterates Strong Buy Rating on RadNet (RDNT)
- RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
- RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
- RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026
Entities mentioned with RDNT
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Jefferies & Co | View Related Stories »
- 13G | View Related Stories »
- Show More...
